Source 1primary paper2026MED
Toolkit/engineered bacteriophages
engineered bacteriophages
Also known as: engineered phages, personalized phage therapies
Taxonomy: Mechanism Branch / Architecture. Workflows sit above the mechanism and technique branches rather than replacing them.
Summary
Engineered bacteriophages are emerging as a promising class of precision antimicrobials... Advances in synthetic biology and nanotechnology have made it possible to redesign phages with enhanced specificity, expanded functionality, and improved stability, positioning them as versatile tools for microbiota-centered therapies.
Usefulness & Problems
Why this is useful
Engineered bacteriophages are presented as precision antimicrobials redesigned for enhanced specificity, expanded functionality, and improved stability in gut-related applications.; precision antimicrobial intervention in the gut; microbiota-centered therapies; applications in IBD, CRC, and infectious enteritis
Source:
Engineered bacteriophages are presented as precision antimicrobials redesigned for enhanced specificity, expanded functionality, and improved stability in gut-related applications.
Source:
precision antimicrobial intervention in the gut
Source:
microbiota-centered therapies
Source:
applications in IBD, CRC, and infectious enteritis
Problem solved
They aim to address the poor selectivity of conventional antibiotics and their failure to restore microbial ecology in gastrointestinal disease settings.; lack of selectivity of conventional antibiotics; failure to restore microbial ecology with conventional antibiotics
Source:
They aim to address the poor selectivity of conventional antibiotics and their failure to restore microbial ecology in gastrointestinal disease settings.
Source:
lack of selectivity of conventional antibiotics
Source:
failure to restore microbial ecology with conventional antibiotics
Problem links
failure to restore microbial ecology with conventional antibiotics
LiteratureThey aim to address the poor selectivity of conventional antibiotics and their failure to restore microbial ecology in gastrointestinal disease settings.
Source:
They aim to address the poor selectivity of conventional antibiotics and their failure to restore microbial ecology in gastrointestinal disease settings.
lack of selectivity of conventional antibiotics
LiteratureThey aim to address the poor selectivity of conventional antibiotics and their failure to restore microbial ecology in gastrointestinal disease settings.
Source:
They aim to address the poor selectivity of conventional antibiotics and their failure to restore microbial ecology in gastrointestinal disease settings.
Taxonomy & Function
Primary hierarchy
Mechanism Branch
Architecture: A delivery strategy grouped with the mechanism branch because it determines how a system is instantiated and deployed in context.
Techniques
Computational DesignTarget processes
manufacturingtranslationImplementation Constraints
cofactor dependency: cofactor requirement unknownencoding mode: externally suppliedimplementation constraint: context specific validationoperating role: delivery
The abstract states that advances in synthetic biology and nanotechnology enable phage redesign, implying these engineering capabilities are prerequisites.; requires synthetic biology and nanotechnology-enabled redesign; clinical translation depends on stability, resistance mitigation, and scalable manufacturing
The abstract explicitly notes unresolved challenges in long-term stability, resistance avoidance, and scalable manufacturing.; long-term stability remains a challenge; resistance development remains a challenge; scalable manufacturing remains a challenge
Validation
Cell-freeBacteriaMammalianMouseHumanTherapeuticIndep. Replication
Supporting Sources
Ranked Claims
Engineered bacteriophages are discussed as microbiota-centered therapeutic tools with applications in inflammatory bowel disease, colorectal cancer, and infectious enteritis.
Advances in synthetic biology and nanotechnology have made it possible to redesign phages with enhanced specificity, expanded functionality, and improved stability.
The review highlights pathogen targeting, immune modulation, and barrier protection as key mechanistic themes for engineered bacteriophages in gut health.
Engineered bacteriophages are emerging as a promising class of precision antimicrobials for gut-related disease contexts.
Long-term stability, resistance development, and scalable manufacturing remain challenges for clinical translation of personalized phage therapies.
Approval Evidence
1 source5 linked approval claimsfirst-pass slug engineered-bacteriophages
Engineered bacteriophages are emerging as a promising class of precision antimicrobials... Advances in synthetic biology and nanotechnology have made it possible to redesign phages with enhanced specificity, expanded functionality, and improved stability, positioning them as versatile tools for microbiota-centered therapies.
Source:
application scopesupports
Engineered bacteriophages are discussed as microbiota-centered therapeutic tools with applications in inflammatory bowel disease, colorectal cancer, and infectious enteritis.
Source:
engineering capabilitysupports
Advances in synthetic biology and nanotechnology have made it possible to redesign phages with enhanced specificity, expanded functionality, and improved stability.
Source:
mechanistic scopesupports
The review highlights pathogen targeting, immune modulation, and barrier protection as key mechanistic themes for engineered bacteriophages in gut health.
Source:
therapeutic positioningsupports
Engineered bacteriophages are emerging as a promising class of precision antimicrobials for gut-related disease contexts.
Source:
translation challengesupports
Long-term stability, resistance development, and scalable manufacturing remain challenges for clinical translation of personalized phage therapies.
Source:
Comparisons
Source-stated alternatives
Conventional antibiotics are the main contrasted approach, described here as less selective and less able to restore microbial ecology.
Source:
Conventional antibiotics are the main contrasted approach, described here as less selective and less able to restore microbial ecology.
Source-backed strengths
enhanced specificity; expanded functionality; improved stability; versatile therapeutic positioning
Source:
enhanced specificity
Source:
expanded functionality
Source:
improved stability
Source:
versatile therapeutic positioning
Compared with Adeno-associated virus
engineered bacteriophages and Adeno-associated virus address a similar problem space because they share manufacturing, translation.
Shared frame: same top-level item type; shared target processes: manufacturing, translation; shared mechanisms: translation_control
Strengths here: may avoid an exogenous cofactor requirement.
Relative tradeoffs: appears more independently replicated.
Compared with theranostic nanoparticles
engineered bacteriophages and theranostic nanoparticles address a similar problem space because they share manufacturing, translation.
Shared frame: same top-level item type; shared target processes: manufacturing, translation; shared mechanisms: translation_control
Compared with virus-like particles
engineered bacteriophages and virus-like particles address a similar problem space because they share manufacturing, translation.
Shared frame: same top-level item type; shared target processes: manufacturing, translation; shared mechanisms: translation_control
Relative tradeoffs: appears more independently replicated; looks easier to implement in practice.
Ranked Citations
- 1.